Hypertriglyceridemia: a too long unfairly neglected major cardiovascular risk factor.

Cardiovasc Diabetol · 2014 · PMC4264548 · PMID 25471221

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

From a clinical point of view, in all available 5 randomized control trials the beneficial effects of major fibrates (gemfibrozil, fenofibrate, bezafibrate) were clearly demonstrated and were highly significant in patients with hypertriglyceridemia [ 163 - 168 ].

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.